Comments
Strides Shasun today said its wholly-owned subsidiary has received approval from the US health regulator for Acteazolamide tablets, used to prevent and reduce symptoms of altitude sickness.
In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for Acteazolamide tablets USP, 125mg and 250 mg.
The approved product is a generic version of Diamox tablets.
Strides said the product, to be launched immediately, will be marketed by Strides Pharma Inc in the US.
Citing IMS sales data, the company said the US market for Acteazolamide tablets is approximately $53 million.
The company’s stock was trading 0.72 per cent higher at Rs 832.35 per scrip on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.